mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.3 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.3 |
mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
-0.048 |
0.3 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.3 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.046 |
0.3 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.03 |
0.3 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.3 |